MEENA BANSAL

Allopathic & Osteopathic Physicians|Internal Medicine|Hepatology NEW YORK, NY NPI 1962432476

General Payments — all program years on this page

$160,903.31

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 117
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $97,046.98 across 56 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $86,959.1514
Travel and Lodging $7,937.1021
Food and Beverage $2,150.7321

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $17,289.7519
2019 $1,930.914
2020 $128.685
2021 $5,079.595
2022 $7,859.435
2023 $31,567.9723
2024 $97,046.9856

Records — PY2024 (56)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1091990743 Ipsen Biopharmaceuticals, Inc $32.91 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096626062 Novo Nordisk Inc $170.20 11/19/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1096716037 Novo Nordisk Inc $3,100.00 10/29/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1096857271 Novo Nordisk Inc $8,331.25 09/20/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1096920170 Novo Nordisk Inc $685.24 11/19/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1096957412 Novo Nordisk Inc $11,818.75 04/13/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1097086954 Novo Nordisk Inc $224.39 04/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097227805 Novo Nordisk Inc $20.00 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097492343 Novo Nordisk Inc $6,781.25 10/31/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1097492837 Novo Nordisk Inc $303.67 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097493864 Novo Nordisk Inc $665.79 04/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1097494089 Novo Nordisk Inc $115.03 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097494111 Novo Nordisk Inc $348.34 10/31/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1097495619 Novo Nordisk Inc $180.00 04/15/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1097496236 Novo Nordisk Inc $327.43 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097496582 Novo Nordisk Inc $199.95 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097497604 Novo Nordisk Inc $876.82 09/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1097497651 Novo Nordisk Inc $3,875.00 03/18/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1097497691 Novo Nordisk Inc $327.38 10/31/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1097498026 Novo Nordisk Inc $438.49 10/31/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1097499019 Novo Nordisk Inc $868.29 04/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1097557881 Novo Nordisk Inc $706.03 04/15/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1097693520 Novo Nordisk Inc $10,656.25 11/19/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1097693895 Novo Nordisk Inc $387.50 04/14/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1097693958 Novo Nordisk Inc $283.19 04/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1097838594 Novo Nordisk Inc $207.19 09/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1097838618 Novo Nordisk Inc $9,881.25 04/15/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1115822601 GlaxoSmithKline, LLC. $800.00 06/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1116467174 GlaxoSmithKline, LLC. $2,062.50 10/02/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1116558067 GlaxoSmithKline, LLC. $8,685.40 01/03/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1118251732 Boehringer Ingelheim Pharmaceuticals, Inc. $13.69 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118251734 Boehringer Ingelheim Pharmaceuticals, Inc. $16.50 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118251736 Boehringer Ingelheim Pharmaceuticals, Inc. $22.85 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118251738 Boehringer Ingelheim Pharmaceuticals, Inc. $35.00 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118251740 Boehringer Ingelheim Pharmaceuticals, Inc. $35.00 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118251742 Boehringer Ingelheim Pharmaceuticals, Inc. $90.92 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118251744 Boehringer Ingelheim Pharmaceuticals, Inc. $102.43 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118251746 Boehringer Ingelheim Pharmaceuticals, Inc. $140.00 08/07/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118251748 Boehringer Ingelheim Pharmaceuticals, Inc. $140.00 12/03/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118251750 Boehringer Ingelheim Pharmaceuticals, Inc. $166.75 07/30/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118251752 Boehringer Ingelheim Pharmaceuticals, Inc. $216.58 07/18/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118251754 Boehringer Ingelheim Pharmaceuticals, Inc. $280.50 07/19/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118251756 Boehringer Ingelheim Pharmaceuticals, Inc. $2,940.00 10/11/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1118251758 Boehringer Ingelheim Pharmaceuticals, Inc. $8,085.00 12/03/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1118251760 Boehringer Ingelheim Pharmaceuticals, Inc. $9,555.00 08/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1141572215 Merck Sharp & Dohme LLC $108.00 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141572217 Merck Sharp & Dohme LLC $115.00 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141572219 Merck Sharp & Dohme LLC $142.00 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141572221 Merck Sharp & Dohme LLC $164.44 03/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141572223 Merck Sharp & Dohme LLC $276.67 03/19/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141572225 Merck Sharp & Dohme LLC $87.00 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141572229 Merck Sharp & Dohme LLC $349.44 03/19/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141572231 Merck Sharp & Dohme LLC $445.76 03/19/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1144161145 Madrigal Pharmaceuticals $78.27 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144161147 Madrigal Pharmaceuticals $42.53 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144161149 Madrigal Pharmaceuticals $38.16 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.